Abstract:Background Pathophysiological changes of Huntington's disease (HD) can precede symptom onset by decades. Robust imaging biomarkers are needed to monitor HD progression, especially before the clinical onset. Purpose To investigate iron dysregulation and microstructure alterations in subcortical regions as HD imaging biomarkers, and to associate such alterations with motor and cognitive impairments. Study Type Prospective. Population Fourteen individuals with premanifest HD (38.0 ± 11.0 years, 9 females; far‐from‐onset N = 6, near‐onset N = 8), 21 manifest HD patients (49.1 ± 12.1 years, 11 females), and 33 age‐matched healthy controls (43.9 ± 12.2 years, 17 females). Field Strength/Sequence 7 T, T1‐weighted imaging, quantitative susceptibility mapping, and diffusion tensor imaging. Assessment Volume, susceptibility, fractional anisotropy (FA), and mean diffusivity (MD) within subcortical brain structures were compared across groups, used to establish HD classification models, and correlated to clinical measures and cognitive assessments. Statistical Tests Generalized linear model, multivariate logistic regression, receiver operating characteristics with the area under the curve (AUC), and likelihood ratio test comparing a volumetric model to one that also includes susceptibility and diffusion metrics, Wilcoxon paired signed‐rank test, and Pearson's correlation. A P‐value <0.05 after Benjamini–Hochberg correction was considered statistically significant. Results Significantly higher striatal susceptibility and FA were found in premanifest and manifest HD preceding atrophy, even in far‐from‐onset premanifest HD compared to controls (putamen susceptibility: 0.027 ± 0.022 vs. 0.018 ± 0.013 ppm; FA: 0.358 ± 0.048 vs. 0.313 ± 0.039). The model with additional susceptibility, FA, and MD features showed higher AUC compared to volume features alone when differentiating premanifest HD from HC (0.83 vs. 0.66), and manifest from premanifest HD (0.94 vs. 0.83). Higher striatal susceptibility significantly correlated with cognitive deterioration in HD (executive function: r = −0.600; socioemotional function: r = −0.486). Data Conclusion 7 T MRI revealed iron dysregulation and microstructure alterations with HD progression, which could precede volume loss, provide added value to HD differentiation, and might be associated with cognitive changes. Evidence Level 2 Technical Efficacy Stage 2

Neurovascular abnormalities in humans and mice with Huntington's disease.

Aberrant Astrocytes Impair Vascular Reactivity in Huntington Disease

Longitudinal alterations in brain perfusion and vascular reactivity in the zQ175DN mouse model of Huntington's disease

Magnetic Resonance Imaging to Detect Structural Brain Changes in Huntington's Disease: A Review of Data from Mouse Models

Altered Iron and Microstructure in Huntington's Disease Subcortical Nuclei: Insight From 7T MRI

Detection of Cerebrovascular Loss in the Normal Aging C57BL/6 Mouse Brain Using in vivo Contrast-Enhanced Magnetic Resonance Angiography

Abstract WP262: Three-dimensional Characterization Of Cerebral Microvasculature And Microhemorrhages

Linking White Matter and Deep Gray Matter Alterations in Premanifest Huntington Disease.

Glymphatic influx and clearance are perturbed in Huntington's disease

Impairment of cerebral vascular reactivity and resting blood flow in early-staged transgenic AD mice: in vivo optical imaging studies

The contribution of preclinical magnetic resonance imaging and spectroscopy to Huntington's disease

Super-Resolution Ultrasound Reveals Cerebrovascular Impairment in a Mouse Model of Alzheimer's Disease

Developmental alterations of indirect-pathway medium spiny neurons in mouse models of Huntington's disease.

Characterizing differences in retinal and choroidal microvasculature and structure in individuals with Huntington's Disease compared to healthy controls: A cross-sectional prospective study

Early alterations of motor learning and corticostriatal network activity in a Huntington's disease mouse model

Mapping the Cerebrovascular Abnormality in Transgenic Alzheimer's Disease (AD) Mice with deep-learning-based super-resolution cerebral blood volume (CBV)-MRI

High‐Spatiotemporal‐Resolution Ultrasound Flow Imaging to Determine Cerebrovascular Hemodynamics in Alzheimer's Disease Mice Model

Retinal dysfunction in Huntington's disease mouse models concurs with local gliosis and microglia activation

White Matter Microstructure Changes Revealed by Diffusion Kurtosis and Diffusion Tensor Imaging in Mutant Huntingtin Gene Carriers

Resting-state functional MRI reveals altered brain connectivity and its correlation with motor dysfunction in a mouse model of Huntington’s disease